Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
deepmirror logo — The foundation model for drug design

deepmirror

The foundation model for drug design

Founded 2019 United Kingdom London, United Kingdom 15 employees Pre-Seed Biotechnology, Life Sciences

General Information

Company Name deepmirror
Founded Year 2019
Location United Kingdom London, United Kingdom
Employees 15
Industries Biotechnology, Life Sciences
Funding Stage Pre-Seed
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with deepmirror. To contact deepmirror, visit deepmirror.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does deepmirror compare?

A PDF of deepmirror and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting deepmirror soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About deepmirror

deepmirror, founded in 2019, is revolutionizing drug discovery through its modern software specifically designed for chemists. With the goal to "Step up your molecule discovery," this UK-headquartered company operates primarily within the Biotechnology and Life Sciences industries.

The company recently attracted attention with its latest financing milestone being a Pre Seed Round investment on 31 July 2024, indicating early validation and interest in its innovative approach. This infusion of capital was led by bond-st, a noteworthy detail that highlights investor confidence in deepmirror's potential to enhance efficiency and innovation in drug design.

As deepmirror continues to develop its technology within this pivotal sector, prospective investors should focus on its ability to intersect cutting-edge software with biochemical advancements, positioning itself as a valuable contender capable of reshaping modern drug design landscapes.

Business keywords: Molecule Discovery, Drug Design Software, Chemistry AI Platform, AI-Powered Drug Discovery, Deep Learning in Medicine, Data Science in Biology, AI in Chemistry, Biological Data Analysis, Machine Learning in Drug Development, Pharmaceutical Innovation, Image Analysis in Drug Discovery, AI-Enhanced Drug Candidates, Biotechnology Software

Services & Products

AI for hit-to-candidate molecule design
Data-driven potency and ADMET prediction
Generative AI for novel molecule discovery
Structure-guided design and hypothesis testing

Target Customers

Pharmaceutical Companies Biotech Startups Academic Researchers Medicinal Chemists Drug Discovery Teams

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round Undisclosed 1
bond-st
31 Jul 2024
Grant Undisclosed 1
Innovate UK
Innovate UK
14 Feb 2023
Pre Seed Round Undisclosed -
31 Aug 2022
Grant Undisclosed 1
Innovate UK
Innovate UK
01 Jul 2022

deepmirror Alternatives & Competitors

View All Alternatives
deepmirror vs
Integrated Biosciences, Inc.
Integrated Biosciences, Inc. United States

Unravelling complex biology with optogenetics, chemistry and computation for small molecule discover...

Seed
18 employees
Biopharma, Biotechnology
deepmirror vs
AsedaSciences®
AsedaSciences® Switzerland

Helping scientists develop safer chemicals

11 employees
Biotechnology, Life Sciences
deepmirror vs
Nexo Therapeutics
Nexo Therapeutics United States

We’re driven to translate the most compelling and still undrugged targets in human biology into med...

Series A
19 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About deepmirror

The foundation model for drug design
deepmirror was founded in 2019.
deepmirror is headquartered in London, United Kingdom.
deepmirror operates in Biotechnology and Life Sciences. Its work centres on Molecule Discovery, Drug Design Software, Chemistry AI Platform and AI-Powered Drug Discovery. Its customers include Pharmaceutical Companies, Biotech Startups and Academic Researchers.
deepmirror has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Tiered Pricing.
deepmirror has approximately 15 employees.
deepmirror has completed 4 funding rounds. The latest funding stage is Pre-Seed.
deepmirror offers: AI for hit-to-candidate molecule design, Data-driven potency and ADMET prediction, Generative AI for novel molecule discovery, Structure-guided design and hypothesis testing.
Top alternatives and competitors to deepmirror include Integrated Biosciences, Inc., AsedaSciences®, Nexo Therapeutics, Octant, Numerate. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
deepmirror and Integrated Biosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for deepmirror, https://bouncewatch.com/company/deepmirror, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes